1. Home
  2. OCS vs SCSC Comparison

OCS vs SCSC Comparison

Compare OCS & SCSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • SCSC
  • Stock Information
  • Founded
  • OCS 2003
  • SCSC 1992
  • Country
  • OCS Switzerland
  • SCSC United States
  • Employees
  • OCS N/A
  • SCSC N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • SCSC Retail: Computer Software & Peripheral Equipment
  • Sector
  • OCS Health Care
  • SCSC Technology
  • Exchange
  • OCS Nasdaq
  • SCSC Nasdaq
  • Market Cap
  • OCS 916.3M
  • SCSC 892.1M
  • IPO Year
  • OCS N/A
  • SCSC 1994
  • Fundamental
  • Price
  • OCS $21.41
  • SCSC $37.20
  • Analyst Decision
  • OCS Strong Buy
  • SCSC Hold
  • Analyst Count
  • OCS 5
  • SCSC 1
  • Target Price
  • OCS $28.80
  • SCSC N/A
  • AVG Volume (30 Days)
  • OCS 64.5K
  • SCSC 236.7K
  • Earning Date
  • OCS 03-17-2025
  • SCSC 01-30-2025
  • Dividend Yield
  • OCS N/A
  • SCSC N/A
  • EPS Growth
  • OCS N/A
  • SCSC N/A
  • EPS
  • OCS N/A
  • SCSC 2.54
  • Revenue
  • OCS $1,027,571.00
  • SCSC $3,021,788,000.00
  • Revenue This Year
  • OCS $7.98
  • SCSC N/A
  • Revenue Next Year
  • OCS $853.39
  • SCSC $6.58
  • P/E Ratio
  • OCS N/A
  • SCSC $14.67
  • Revenue Growth
  • OCS N/A
  • SCSC N/A
  • 52 Week Low
  • OCS $10.55
  • SCSC $36.63
  • 52 Week High
  • OCS $23.08
  • SCSC $53.90
  • Technical
  • Relative Strength Index (RSI)
  • OCS 52.07
  • SCSC 25.01
  • Support Level
  • OCS $20.95
  • SCSC $36.71
  • Resistance Level
  • OCS $21.86
  • SCSC $37.81
  • Average True Range (ATR)
  • OCS 0.56
  • SCSC 1.17
  • MACD
  • OCS -0.26
  • SCSC -0.07
  • Stochastic Oscillator
  • OCS 56.18
  • SCSC 12.45

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About SCSC ScanSource Inc.

ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: